Related Experiment Videos
[MRSA ocular infections]
Abstract:
Staphylococcus aureus and Staphylococcus epidermidis are organisms that frequently cause conjunctivitis, keratitis and endophthalmitis. MRSA comprised about 25% of the S. aureus isolated from ocular infections; most were from compromised host. MRSA was resistant to penicillins, cephems and macrolides but was sensitive to amikacin, netilmicin, minocycline and ofloxacin. Ofloxacin-resistant strains, however increased rapidly. Topical vancomycin, arbekacin and minocycline were used when commercially available antibiotics were inadequate.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) causes serious ocular infections. While sensitive to certain antibiotics, rapid development of ofloxacin resistance necessitates alternative treatments like vancomycin for effective management.
Area of Science:
- Ophthalmology
- Microbiology
- Infectious Diseases
Background:
- Staphylococcus aureus and Staphylococcus epidermidis are common causes of ocular infections, including conjunctivitis, keratitis, and endophthalmitis.
- Methicillin-resistant Staphylococcus aureus (MRSA) accounts for approximately 25% of S. aureus isolates from ocular infections, particularly in immunocompromised patients.
Observation:
- MRSA strains exhibit resistance to penicillins, cephems, and macrolides.
- These MRSA strains remain sensitive to amikacin, netilmicin, minocycline, and ofloxacin.
- A rapid increase in ofloxacin-resistant MRSA strains has been observed.
Findings:
- Topical vancomycin, arbekacin, and minocycline are effective therapeutic options when standard antibiotics are insufficient.
- The emergence of antibiotic resistance in ocular pathogens poses a significant clinical challenge.
Implications:
- Alternative antibiotic strategies are crucial for managing MRSA ocular infections, especially in the face of rising resistance.
- Further research into novel antimicrobial agents and treatment protocols for resistant ocular infections is warranted.